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1.Theglobalprevalenceof
diabetesinolderpeopleis
11%andmanyolderpeople
willhaveundiagnosed
diabetesbecausesymptoms
areatypicalandnon-specific,
andoftenattributedtoage.
2.TheInternationalDiabetes
Federation(IDF)Global
GuidelineforManaging
OlderPeoplewithType2
Diabetesseekstoaddress
thelackofawarenessaround
theeffectsofdiabeteson
ageingandviceversa..
3.Diabetesspecialistnursesand
practicenursescanhavea
keyroleoperationalisingthe
guidelineintheirpracticeareas
byusingtherecommendations
intheguidelinetodevelop
newpoliciesandprocedures
orreviseexistingpolicies
andprocessesofcare.
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Managing older people with diabetes is complex due to multimorbidities, functional 
changes and polypharmacy, and there is little randomised control trial evidence to 
support recommendations.  Significantly, there is a global lack of awareness about the 
effects of diabetes on ageing and vice versa. The International Diabetes Federation 
(IDF) Global Guideline for Managing Older People with Type 2 Diabetes seeks to 
address these issues. The guideline was launched by the IDF President, Sir Michael 
Hirst during a satellite symposium about diabetes in older people held in association 
with the World Diabetes Congress in Melbourne in December 2013. This article 
provides an overview of the IDF Guideline and suggests some ways DSNs and practice 
nurses can implement the guidelines in practice.
The global prevalence of diabetes in older people is 11% (International Diabetes Federation [IDF] Atlas, 2013) and older 
people make up 25% of the adult population 
(IDF, 2013). A significant proportion of older 
people have undiagnosed diabetes but the 
diagnosis is often missed or delayed because 
symptoms are atypical and non-specific, and 
often attributed to age (Chiasson et al, 2002; 
IDF Atlas, 2013).  Diabetes is a major cause 
of complications, falls, reduced quality of life 
and changed physical and mental functioning 
in older people (Kirkman, 2012; Zhang et 
al, 2012), depression (Cahoon, 2012) and is a 
leading cause of death from cardiovascular and 
other complications (Zhang et al, 2012). 
Changes in glucose homeostasis, 
counter-regulatory and other hormones, and 
end organ function, such as renal and liver 
disease, and cardiovascular function affect 
medicine safety and choices and functional 
status (Ginsberg et al, 2005; Meneilly et al, 
2011). The progressive decline in beta cell 
function and first phase insulin response 
means many older people eventually require 
insulin.  Care is often suboptimal and does not 
take account of these physiological changes or 
functional status (Sinclair and Morley 2013a; 
Wellard et al, 2013).
Although, several guidelines developed for 
adults with diabetes contain small sections 
about managing older people with diabetes, 
they do not take account of the changed 
pathophysiology in older people, the effects 
on functional status, disability and frailty, 
polypharmacy and the implications for safety 
and quality of life (Cheung et al, 2009; Scottish 
Intercollegiate Network (SIGN) 2010; NICE, 
2011). Interestingly, the Royal Australian 
College of General Practitioners’ publication, 
Medical Care of Older Persons in Residential 
Aged Care Facilities, known locally as the 
“Silver Book”, does not include diabetes. In 
2012, Sinclair and colleagues released a position 
statement on behalf of the International 
Association of Gerontology and Geriatrics 
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(IAGG), The European Diabetes Working 
Party for Older People (EDWOP) and the 
International Taskforce of Experts in Diabetes, 
which paved the way for the IDF Global 
Guideline.
The IDF guideline for older people with 
type 2 diabetes
Guidelines are designed to be used to guide 
clinical decisions after a comprehensive 
assessment of the individual and their situation 
has been completed.  In addition, guideline 
recommendations need to be operationalised to 
suit specific groups of people and care settings. 
The best guidelines are developed following 
agreed guideline development processes, as was 
the case with all IDF guidelines.
The purpose of the IDF Global Guideline 
is to outline an international approach to 
caring for older people with diabetes, provide 
guidance about the philosophy behind the 
principles of care of older people with diabetes 
and foster a collaborate approach within the 
interdisciplinary care team.
The development process generally consists of 
forming an expert writing group, undertaking 
a systematic literature review, determining the 
quality of the evidence and synthesising the 
information into relevant guidelines, public 
consultation about the draft guidelines and 
incorporating relevant comments into the final 
guideline document. 
There is little randomised control trial 
evidence directly applicable to older people 
with diabetes because they are usually excluded 
from such trials (Bugeia et al 1997; Bayer and 
Tadd 2000). Even when well-designed studies 
are available, the information cannot always 
be generalised to individual older people, 
or extrapolated to older cohorts (University 
of Michigan, 2011). Thus, a set of guiding 
principles was developed to serve as the 
philosophical framework for the IDF Global 
Guideline.  This strategy has been used to 
develop other guidelines when there was very 
little evidence and has been found to add value 
to the evidence base and clinical applicability of 
the resultant guidelines (Dunning et al, 2012; 
2014).
Core principles of the guideline
The core principles of the Global Guideline are 
outlined below:
l “One size does not f it all”.
l Older people with diabetes are highly 
individual; they are not a homogenous group. 
Therefore, care must be designed alongside 
the older person and/or their family or carers 
to suit their functional status, social situation 
and life expectancy. The care plan must be 
holistic and personalised.
l Care should be guided by the findings of 
regular comprehensive assessments and 
regular medicine reviews.
l Care should be safe for the individual 
considering the risk/benefit ratio and life 
expectancy.
l Prevention has a key place in care and should 
consist of identifying relevant individual 
risks and planning care to manage those 
risks. Significant risks include cardiovascular 
disease, falls, medicine-related adverse 
events, pain and functional decline leading to 
disability and frailty.
l Careful use of medicines and 
pharmacovigilance are essential to minimise 
polypharmacy and the associated risks of 
medicine errors and adverse events.
l The needs of family and/or carers must 
be considered, particularly as some family 
member or carers will also be old and have 
their own health problems.
Outline of the guideline contents
One of the intital challenges faced by the 
guideline development group was defining 
“older people”. A range of ages has been used 
to categorise older people in the literature but 
there is no consensus definition. Furthermore, 
chronological age does not indicate how an 
older person manages their life, or indicate the 
best treatment outcomes (Sinclair et al, 2012; 
Dunning et al, 2014) Thus, for the purpose 
of the guidelines, older people refers to people 
aged 70 and older and the care focus is on 
functional status rather than on age.
The guideline consists of 14 individual 
guidelines, or chapters, that address key 
care issues such as screening and diagnosis, 
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education, depression, risks such as 
cardiovascular risk, frailty, delirium and falls, 
management in care homes and end-of-life care. 
It also includes a chapter on sexual health and 
other special considerations. Care is described 
in each individual guideline according three 
main functional categories:
l Category 1: Functionally independent.
l Category 2: Functionally dependent, which 
has two subcategories:  
– Frail: Frail older people are less able to 
tolerate the stress of illness, which is likely 
to increase the risk of falls and admission 
to hospital. However, frail older people can 
undertake some self-care with support.
– Dementia.
l Category 3: End-of-life, which refers to 
the last stages of life, defined as stable 
or unstable, deteriorating and terminal 
(Palliative Care Outcomes Collaborative, 
2008); this generally refers to the last 
12 months of life. People with diabetes 
can have long periods of stable/unstable 
diabetes before they enter the deteriorating 
and terminal phases of care. Significantly, 
palliative approaches can be combined with 
active treatment in frail older people and 
those with end-stage renal disease, and liver 
and cardiovascular disease to manage pain, 
improve comfort and quality of life.
Box 2 suggests some key issues that need to be 
considered when planning care for older people 
with diabetes. 
Challenges of caring for older people
Planning care for older people with diabetes 
is very challenging because of diabetes 
complications, such as sensory, mental health, 
cognitive and physical changes, which can all 
impact on learning capability, functional status, 
self-care capacity, safety and independence. 
These factors increase the risk of falling, 
developing pressure ulcers, including foot 
ulcers, depression and pain.  Pain is often not 
recognised and frequently treated inadequately 
(Royal College of Physicians/British Geriatrics 
Society, 2007). These issues are outlined in Box 1.
Frailty is highly prevalent with increasing age 
and confers a high risk of adverse outcomes, 
such as admission to hospital and/or care 
homes, falls and death (Freid et al, 2001; 
Sinclair and Morley, 2013b). Significantly, 
frailty is not synonymous with comorbidity 
or disability but comorbidity is a risk factor 
for frailty, and disability is consequently an 
outcome of frailty. It is important to identify 
older people at risk of frailty. Diabetes 
complications, frailty and dementia also make 
it diff icult for the person to exercise and 
undertake diabetes and other self-care activities.
Hyperglycaemia is often regarded as relatively 
unimportant in older people ‘because we are 
not trying to stop complications’ but it is not 
a benign condition and should be managed to 
promote comfort, quality of life and reduce 
the cognitive effects of hyperglycaemia 
(Crane et a, 2013; Seaquist et al, 2013).  In 
addition, hyperglycaemia may be a risk factor 
for dementia (Crane et al, 2013).  Managing 
hyperglycaemia is an important aspect of 
reducing cardiovascular risk along with 
controlling blood pressure, lipids and not 
smoking.  
Hypoglycaemia is a significant risk for all 
older people treated with most glucose-lowering 
medicines because of the associated decline 
in renal (Yun et al, 2012) and liver function, 
circulatory changes, nutrition deficits and 
declining production of key counter-regulatory 
hormones, such as glucagon, which result in 
changed symptomology and predominance 
Box 1. Some common geriatric syndromes 
DSNs and PNs are likely to encounter 
caring for older people with diabetes.
lFalls.
lPain.
lUrinarytractinfection.
lCognitive impairment, which can be assessed
usingMini-MentalStateExamination(Folsteinet
al,1975).
lDepression, which can be assessed using the
Patient Health Questionnaire (Kroenke et al,
2001).
lHypoglycaemia.
lDelirium.
lPolypharmacy(usuallymorethanfivemedicines).
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of neuroglycopenic symptoms (Meneilly et 
al. 2011; Seaquist et al, 2013). In the short 
term, hypoglycaemia affects delayed and 
working memory (Feinkohl et al, 2013) 
and can precipitate myocardial infarction 
(Chopra and Kewal, 2012). In the longer term, 
hypoglycaemia is associated with dementia 
(Greco et al, 2010).  
Older people are at high risk of 
medicine-related adverse events and errors, and 
admission to hospital or a care home for older 
people (Gurwitz et al. 2003; Budnitz et al. 
2008). Thus, pharmacovigilance is essential. 
There is strong evidence that many medicines 
commonly prescribed for older people should 
not be used or should be used with caution; 
Box 2. Key issues to consider when planning care with older people with diabetes
Careplansneedtobedevelopedwiththeindividualand/ortheirfamilycarerstoensuretheysuittheindividual’sgoals,healthstatusandlife
expectancyandhelptheindividualliveindependentlyaslongaspossible.DSNsanPNsplayanimportantroleinplanningcareforolder
peoplewithdiabetesandcanensurecareplansencompass:
l Screeningolderpeopleforundiagnoseddiabetes.
l Proactivelyundertakingcomprehensiveriskassessmentstoidentifyandmanage:
– Diabetescomplications,includingrenalandliverdisease,whichaffectmedicinechoicesandpredisposestheindividualtohypoglycaemia
andanaemia.
– Inadequatenutrition,whichalsoaffectsmedicinechoices;lowvitaminDandB12arecommonandthelattercancompoundanaemia.
– Pain.
– Fallsrisk;apartfromperipheralneuropathy,diabetes-specificfallsriskfactorsarenotincludedonmostfalls-risktoolsincommonuse.
– Delirium.
– Increasingfrailty.
– Geriatricsyndromes(Box 1).
– Unsafedriving.
– Hypo-andhyperglycaemiarisk.
l Individualisingbloodglucose,HbA1c,bloodpressure(BP)andothercaretargetstosuittheindividual’sfunctionalstatus,forexample:
– Functionallyindependent:HbA1c53–59mmol/mol(7.0–7.5%);BP<140/90mmHg.
– Functionallydependent:HbA1c53–64mmol/mol(7.0–8.0%);BP140/90mmHg.
– Frailanddementia:HbA1c70mmol/mol(upto8.5%)BP150/90mmHg.
l Preventing/managingcardiovasculardisease.Cardiovasculardiseaseshouldbetreatedearlyandeffectivelyusingahealthydiet,activity
andlipid-loweringmedicines,suchasstatins,aspirinandantihypertensivemedicines,suchasACEinhibitors,whichalsoprotectkidney
functionwhenindicatedandsafe.
l Controlling hyperglycaemia to reduce cardiovascular and microvascular disease, enhance self-care, reduce falls risk, avoid
hyperglycaemia-related symptoms, suchas tiredness, thirst and frequenturination,dehydrationand the associated riskof ketoacidosis,
hyperosmolarstates,delirium,cognitiveimpairmentanddepression.However,“tight”bloodglucosecontrolisnotusuallywarrantedand
mayplacethepersonatsignificantriskofhypoglycaemia.
l Conductingregularcomprehensivemedicinereviewsthatincludeaskingaboutherbalmedicinesandotherself-prescribedtreatments.Safe
medicineusecanbeachievedusingaqualityuseofmedicines(QUM)approach(DepartmentofHealthandAging(2002).QUMinvolves:
– choosingmedicineswiselyafterundertakingacomprehensivehealthassessmentandusingnon-medicineoptionswhereappriopriate.
– usingmedicines doses and dose regimens that suit the individual older person andmonitoring the outcomes using regular clinical
assessmentandmedicinereviews.
lAssessingphysicalstatus(functionalstatus),kidneyandliverfunction,mentalhealth,cognitivefunctioningandself-careatleastannually
andwheneverhealthstatusorthecareplanchanges.
lIncludinggeneralhealthassessmentssuchasmammograms,prostatechecks,bowelchecks,thyroidfunction,immunisationstatus,sexual
healthandwellbeingatleastannually.
lHavingearlydiscussionsaboutdevelopingplanstostopdriving,forend-of-lifecareandmovingtosupportedcareoracarehome.
lImplementingalertandcallsystemstoenhancesafetywhenneeded,especiallyforcommunitydwellingolderpeople.
lSupportingcarers.
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for example, antipsychotic medicines are not 
the safest choice to manage dementia-related 
behavioural problems and sliding insulin 
scales are not an appropriate way of managing 
episodes of hyperglycaemia (American 
Geriatrics Society, 2012).
Regular comprehensive medicine reviews 
are needed, especially when several doctors 
prescribe medicines for the same older person. 
Medicines reviews undertaken at home can 
provide important information about the 
individual’s social circumstances and the 
medicine behaviours they might not disclose 
to health professionals during consultations. 
Many medicines prescribed to manage diabetes 
and its complications are classed as high-risk 
medicines because of their side effects and the 
way they are used and metabolised in the body 
(Department of Health, Australia, 2014).
Summary
Box 3 outlines some strategies DSNs and 
practice nurses can use to implement the 
guidelines in clinical practice. Planning 
care for older people should focus on safety, 
maintaining independence, functional status 
and quality of life, managing symptoms, and 
reducing the impact of diabetes complications 
and other diseases on health and well being. 
Individualising management targets is essential 
(Sinclair et al, 2012, Dunning et al, 2014), as 
is involving the older person and their family/
carers in management decision. Education for 
health professionals, older people with diabetes 
and their carers is also vitally important. 
The IDF Global Guideline provides 
recommendations to help DSNs and practice 
nurses develop relevant policies and procedures, 
holistic, personalised care plans for older people 
with diabetes. n
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